PLIN3 knockdown inhibits hepatocellular carcinoma cell proliferation and migration. (IMAGE)
Caption
(A, B) Quantitative PCR and Western blotting analyses of PLIN3 mRNA and protein expression in PLIN3-knockdown Huh7 and PLC/PRF/5 cells, respectively. (C) BODIPY staining was used to assess LD accumulation in PLIN3-knockdown Huh7 and PLC/PRF/5 cells. (D) Measurement of TG content in PLIN3-knockdown Huh7 and PLC/PRF/5 cells. (E) Cell proliferation was assessed via a CCK-8 assay to evaluate the effect of PLIN3 knockdown on Huh7 and PLC/PRF/5 cells. (F, G) Wound healing and migration assays were performed to assess the migration of PLIN3-knockdown Huh7 and PLC/PRF/5 cells. (H) F-actin staining of PLIN3-knockdown Huh7 and PLC/PRF/5 cells was performed to examine cytoskeletal changes. (I) Serum and hepatic TG levels from orthotopic xenografts. (J) Representative images of liver tissues and hematoxylin-eosin-stained tumor sections from orthotopic xenografts. (K) Quantitative analysis of the orthotopic liver tumor burden. All the data are presented as the means ± standard deviation. Statistical significance is indicated as ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001.
Credit
Huiying Gu, Qiumin Wu, Haibei Zhao, JingLong Du, Zhenzhen Zhang, Juan Chen
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND